ArticlePharmacoEconomics2013

Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States.

Kit N Simpson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.